Ecolectro | $10,500,000 | (Nov 15, 2024)
Workflow | $3,000,000 | (Nov 15, 2024)
runQL | $1,600,000 | (Nov 15, 2024)
AATec Medical
Germany
- Munich Area
- 18/07/2023
- Seed
- $3,033,000
AATec Medical GmbH is a biotech company developing a product platform based on recombinant alpha-1 antitrypsin (AAT) for the treatment of inflammatory diseases, virus infections and rare diseases. The first product candidate is a novel AAT formulation for inhalation to treat emerging inflammatory diseases of the lung and respiratory virus infections.
- Industry Biotechnology Research
- Website https://aatec-medical.com/
- LinkedIn https://www.linkedin.com/company/aatec-medical/
Related People
Ruediger JankowskyCo Founder
Germany -
Munich, Bavaria
Senior executive in the biopharmaceutical industry with 20+ years of experience in product development and business development. Passionate about transforming innovation in life sciences into products that make a significant difference to patients.
Track record of successful drug development and commercial licensing of biopharmaceuticals and biosimilars for oncology, autoimmune diseases and rare diseases. In-depth expertise in the development and market launch of digital health products as medical devices. Leader of various international cross-functional teams for R&D, regulatory, business development/licensing, and early launch phases in both, mid-size and corporate environments. Built several start-up companies in the biopharmaceutical and MedTech space.
ELICIT PLANT | $48,000,000 | (Nov 15, 2024)
Sunthetics | $4,000,000 | (Nov 15, 2024)
Vaulted Deep | $32,300,000 | (Nov 15, 2024)
Serenity | $5,500,000 | (Nov 15, 2024)
Airbound | $1,700,000 | (Nov 15, 2024)
Influur | $10,000,000 | (Nov 15, 2024)
Naturbeads | $9,890,632 | (Nov 15, 2024)
TestSprite | $1,500,000 | (Nov 15, 2024)
Impilo | $11,500,000 | (Nov 15, 2024)